jRCT2032210032已完成不适用
Phase III clinical trial to evaluate the diagnostic accuracy of QFR (Quantitative Flow Ratio) using online measurement
Medis medical imaging systems0 个研究点目标入组 191 人开始时间: 2021年5月25日最近更新:
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 发起方
- 入组人数
- 191
- 主要终点
- Diagnostic accuracy of QFR
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
- 分配方式
- Single Arm Study
- 干预模型
- Single Assignment
- 主要目的
- Diagnostic Purpose
- 盲法
- Open(masking Not Used)
入排标准
- 年龄范围
- 20age old over 至 No limit（—）
- 性别
- All
入选标准
- •Patients with stable angina or patients who undergo a secondary assessment of stenosis after AMI - 20 years of age or older
- •Patients who can give written consent to the participation
排除标准
- •Patients who had myocardial infarction within 72 hours
- •Patients with severe asthma or severe chronic obstructive pulmonary disease
- •Patients with severe heart failure
结局指标
主要结局
Diagnostic accuracy of QFR
Evaluate the diagnostic accuracy of QFR with FFR as gold standard
Diagnostic accuracy comparison
Compare the diagnostic accuracy of QFR with that of anatomical assessment by QCA
次要结局
未报告次要终点
研究者
相似试验
进行中（未招募）
不适用
Confirmatory study to evaluate the efficacy and safety of chondroitin sulphate and glucosamine sulphate in combination in the treatment of patients with osteoarthritis of the knee compared to placebo.EUCTR2013-000444-26-ESTedec-Meiji Farma, S.A.
已完成
3 期
A study of Dydrogesterone Tablets for treatment of endometriosis in womeCTRI/2023/03/050698Zydus Healthcare Limited228
已完成
3 期
Phase III clinical trial in determining treatment strategy for patients with High grade T1 bladder cancer who have pT0 histology on the second TUR (JCOG1019, BC pT0 PhaseIII)High grade T1 bladder cancerJPRN-UMIN000006390Japan Clinical Oncology Group (JCOG)260
进行中（未招募）
1 期
Efficacy and safety of delgocitinib cream in adolescents 12-17 years of age with moderate to severe chronic hand eczemaEUCTR2021-006340-27-BEEO Pharma A/S92
进行中（未招募）
1 期
Efficacy and safety of delgocitinib cream in adolescents 12-17 years of age with moderate to severe chronic hand eczemaEUCTR2021-006340-27-FREO Pharma A/S92